As of October 20, 2026, 1,155,535 ETH are waiting in the Ethereum staking activation queue, resulting in an estimated 20-day wait before staking rewards begin. This queue size reflects a protocol limit allowing only 256 ETH activation per epoch, translating to about 57,600 ETH daily. The exit queue has decreased significantly since a MetaMask security incident in late September, now holding 174,282 ETH with a 4-day wait. While the large entry queue indicates strong demand for staking, it does not directly pressure the market price, as these ETH are already purchased and temporarily locked. A proposed protocol upgrade (EIP-8061) aims to increase exit capacity but will not affect the entry queue limit. Investors should consider the wait time when planning staking and note that staking rewards are taxable above certain thresholds, while the holding period for tax exemption continues during the wait.
Ethereum staking queue data provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, 44 out of 50 rose today. Notable movers include XTZ at Rp5,640 (+4.44%), GRT at Rp447 (+4.15%), and ALGO at Rp2,034 (+4.04%). This snapshot is as of Oct 21, 2026 01:21 WIB.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
